Efficacy of Cell-Free and Concentrated Ascites Reinfusion Therapy for Palliative Care in a Patient with Malignant Pleural Mesothelioma: A Case Report
Author:
Affiliation:
1. Department of Thoracic Oncology, National Cancer Center Hospital East
Publisher
Medical Association of Nippon Medical School
Subject
General Medicine
Link
https://www.jstage.jst.go.jp/article/jnms/84/5/84_231/_pdf
Reference17 articles.
1. 1. Britton RC, Nakamoto S: Intravenous infusion of dialyzed, autogenous, ascitic fluid in the management of cirrhotic ascites: a preliminary report of favorable results in six patients. Cleve Clin Q 1960; 27: 82-87.
2. 2. Inoue N, Yamazaki Z, Oda T, Sugiura M, Wada T: Treatment of intractable ascites by continuous reinfusion of the sterilized, cell-free and concentrated ascitic fluid. Trans Am Soc Artif Intern Organs 1977; 23: 699-702.
3. 3. Ueda T, Maehara M, Takahashi Y, Nakayama N, Kondo H, Shirota K, Yoshizato T, Miyamoto S: Clinical significance of cell-free and concentrated ascites re-infusion therapy for advanced and recurrent gynecological cancer. Anticancer Res 2012; 32: 2353-2357.
4. 4. Wang L, Okubo T, Shinsaka M, Kobayashi A, Ogasawara M, Sakaguchi R, Nagai T, Seki H: Efficacy and safety of cell-free and concentrated ascites reinfusion therapy (CART) in gynecologic cancer patients with a large volume of ascites. J Obstet Gynaecol Res 2015; 41: 1614-1620.
5. 5. Matsusaki K, Ohta K, Yoshizawa A, Gyoda Y: Novel cell-free and concentrated ascites reinfusion therapy (KM-CART) for refractory ascites associated with cancerous peritonitis: its effect and future perspectives. Int J Clin Oncol 2011; 16: 395-400.
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Reappraisal of a Renovated Cell-free and Concentrated Ascites Reinfusion Therapy for Malignant Ascites;Anticancer Research;2024-02
2. Reappraisal of a renovated cell-free and concentrated ascites reinfusion therapy (KM-CART) for malignant ascites;2023-09-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3